FDA Recalls Thyroid Meds Across the US - Newser

What the report says

Newser reports that the FDA has issued a nationwide recall involving certain levothyroxine sodium tablets distributed by Major Pharmaceuticals. The reason cited in the available source material is that some pills were found to be subpotent, meaning they may contain less active drug than expected. The public article text available from Newser did not include lot numbers, dosage strengths, recall class, or the date of the FDA notice.

Levothyroxine sodium is commonly prescribed to replace or supplement thyroid hormone, including for people with hypothyroidism. Because dosing can be sensitive, a weaker-than-labeled tablet could matter for patients who depend on a stable dose to manage thyroid hormone levels. The supplied evidence does not specify whether any adverse events were reported or how many bottles or lots are affected.

As general medication-safety context, patients who believe they may have a recalled prescription should check the medication label and contact their pharmacist, prescriber, or the FDA recall notice for product-specific instructions. They should not assume all levothyroxine products are affected, because the report refers only to certain Major Pharmaceuticals pills. More complete recall details would normally be found in the FDA’s official recall posting, including affected NDCs, lot numbers, expiration dates, and recommended next steps.